INCENP Polyclonal antibody
INCENP Polyclonal Antibody for WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
Human and More (1)
Applications
WB, ELISA and More (1)
Conjugate
Unconjugated
验证数据展示
经过测试的应用
| Positive WB detected in | HeLa cells, Raji cells |
推荐稀释比
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:12000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
发表文章中的应用
| WB | See 2 publications below |
| IF | See 2 publications below |
产品信息
29419-1-AP targets INCENP in WB, IF, ELISA applications and shows reactivity with Human samples.
| Tested Applications | WB, ELISA |
| Cited Applications | WB, IF |
| Tested Reactivity | Human |
| Cited Reactivity | human |
| Immunogen | INCENP fusion protein Ag30184 种属同源性预测 |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Full Name | inner centromere protein antigens 135/155kDa |
| Synonyms | FLJ31633, INCENP, Inner centromere protein |
| Calculated Molecular Weight | 105 kDa |
| Observed Molecular Weight | 106-130 kDa |
| GenBank Accession Number | NM_001040694 |
| Gene Symbol | INCENP |
| Gene ID (NCBI) | 3619 |
| RRID | AB_2918303 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NQS7 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
| Storage Conditions | Store at -20°C. Aliquoting is unnecessary for -20oC storage. |
实验方案
| Product Specific Protocols | |
|---|---|
| WB protocol for INCENP antibody 29419-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
发表文章
| Species | Application | Title |
|---|---|---|
Dev Cell The anaphase-promoting complex controls a ubiquitination-phosphoprotein axis in chromatin during neurodevelopment | ||
Int Immunopharmacol Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy |